Agency
Arab American and Chaldean Council
Arab American and Chaldean Council was paid $2.38M by Medicaid between Jan 2018 and Dec 2024, across 44 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoARAB AMERICAN AND CHALDEAN COUNCIL
DEARBORN, MI 48126
DEARBORN, MI 48126
33aNPI1861673543assigned 11/21/2007
33bProvider typeCommunity/Behavioral Health Agency
28Total paid$2.38M
24GClaims76,325
24DCodes billed44
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community/Behavioral Health Agency providers in Michigan
Rank by total paid#85 of 263
Median peer was paid$541K
This provider vs. median4.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,806 | $204K | |
| 2019 | 8,387 | $219K | |
| 2020 | 7,896 | $233K | |
| 2021 | 9,718 | $305K | |
| 2022 | 13,477 | $439K | |
| 2023 | 17,179 | $532K | |
| 2024incomplete | 12,862 | $448K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 8,169 | 7,980 | $690K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 10,080 | 9,197 | $606K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9.5% | 6,079 | 5,553 | $227K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 9.4% | 2,427 | 2,413 | $223K |
| 99385 | 8.7% | 1,938 | 1,930 | $208K | |
| 99386 | 4.1% | 783 | 780 | $97K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.0% | 1,133 | 1,128 | $95K |
| 99383 | 2.4% | 583 | 583 | $58K | |
| 99384 | 2.3% | 480 | 480 | $54K | |
| 36415 | Collection of venous blood by venipuncture | 1.9% | 12,013 | 11,777 | $46K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 674 | 598 | $20K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 98 | 95 | $9K |
32 more codes
| 99382 | <1% | 85 | $8K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 54 | $8K |
| 99406 | <1% | 873 | $7K | |
| 90688 | <1% | 267 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 529 | $3K |
| 0002A | <1% | 79 | $3K | |
| 0001A | <1% | 98 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 12 | $2K |
| 99397 | <1% | 27 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 198 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 105 | $1K |
| 90661 | <1% | 47 | $810.70 | |
| 81002 | <1% | 308 | $763.63 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $750.36 |
| 0003A | <1% | 15 | $567.75 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 367 | $408.13 |
| 93000 | <1% | 40 | $315.24 | |
| 90658 | <1% | 17 | $265.80 | |
| 99000 | <1% | 12 | $90.16 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 29 | $83.44 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 18 | $58.26 |
| 82962 | <1% | 14 | $32.66 | |
| 3080F | <1% | 535 | $5.96 | |
| 3077F | <1% | 1,270 | $5.96 | |
| 3079F | 0% | 3,177 | $0.00 | |
| 3074F | 0% | 3,169 | $0.00 | |
| 3075F | 0% | 1,238 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 341 | $0.00 |
| 3008F | 0% | 16,796 | $0.00 | |
| 3078F | 0% | 1,857 | $0.00 | |
| 91300 | 0% | 84 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 195 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSARAFA, CARMEN (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Arab American and Chaldean Council | Detroit, MI | $26.92M |
| Arab American and Chaldean Council | Dearborn, MI | $2.51M |
| Arab American and Chaldean Council | Troy, MI | $669.29 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.